Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drgs and Industrie Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a related party of Ishita Drugs & Industries Ltd, acquired 390 equity shares of Rs. 10 each through the open market on February 26, 2026. The related party's holding rose marginally from 32,252 shares (1.08%) to 32,642 shares (1.09%) of the company. The total equity share capital of Ishita Drugs & Industries Ltd remains Rs. 2,99,03,000, comprising 29,90,300 shares. The disclosure was filed under SEBI's takeover regulations to report the small incremental purchase.
The acquisition is extremely small (just 0.01% increase in stake) and is unlikely to have any material impact on the stock price or shareholder value. It signals minor insider interest but does not indicate any significant ownership change.